Notably, silenced FAM49B cooperated with oncogenic K-RAS in acquiring a cancer phenotype in a nontumor human pancreatic duct epithelial (HPDE) cell line, highlighting a synergic effect between K-RAS and FAM49B in tumor progression [141]. This evidence concerns the gene KRAS and neoplasm.